Spiriva Respimat

Spiriva Respimat Indications/Uses

tiotropium bromide

Manufacturer:

Boehringer Ingelheim
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
COPD: SPIRIVA RESPIMAT is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, the maintenance treatment of associated dyspnoea and for prevention of exacerbations.
Asthma: SPIRIVA RESPIMAT is indicated as add on maintenance treatment for the improvement of FEV1 in adult patient with severe asthma who remain symptomatic on inhaled fluticasone.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in